Allez Health

FDA Clears Abbott Continuous Glucose Monitors for OTC Use

Abbott is one of several firms targeting wellness enthusiasts with a CGM that can be used by non-diabetics to track metabolic health.

Allez Health Raises $60M for CGM Biosensor

Allez Health has raised $60 million in a Series A for its continuous glucose monitoring (CGM) biosensor platform for connected digital health platforms.